glp-1 drugs for parkinson's disease drug may help with disease, study reports The most extensive research to-date

doi: 10.1016/0167-4838(82)90041-3

An intensive multifactorial cardiovascular risk intervention targeting glycemic, lipid and hypertension management, smoking and other lifestyle factors was shown to reduce the progression and development of cardiac autonomic neuropathy among patients with type 2 diabetes [15]

Published in 1970, their research confirmed the existence of GIP (Brown, Mutt, Pederson)

Philippe et al 1986), includes at least two forms: GLP-1(1-37) and GLP-1(7-37)

doi:10.1016/s0140-6736(25)01185-7 14.A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

However, fewer than half of people get the recommended amount of fiber daily